USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
RURAL TECHNOLOGIES, INC.
Address:
1008 32ND AVENUE
BROOKINGS, SD 57006
Phone:
N/A
URL:
N/A
EIN:
460432479
DUNS:
939726592
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $183,869.00 2
SBIR Phase II $749,985.00 1
STTR Phase I $99,999.00 1
STTR Phase II $749,992.00 1

Award List:

Development of Bioassays for Prion Infectivity Using Human, Deer, or Elk Cells

Award Year / Program / Phase:
2004 / STTR / Phase I
Award Amount:
$99,999.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Kris Fairbanks, Director of Clinical Studies
Research Institution:
National Animal Disease Center
RI Contact:
Adrianna D. Hewings
Abstract:
Originally believed to be due to a unique viral infection, it is now believed that prion diseases or Transmissible Spongiform Encephalopathies (TSEs) are the result of a new, infectious protein (PrPSc). Definitive antemortem tests for TSEs are lacking, primarily due to an inability to expand the… More

Development of Bioassays for Prion Infectivity Using Human, Deer, or Elk Cells

Award Year / Program / Phase:
2005 / STTR / Phase II
Award Amount:
$749,992.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Chris Mateo, Manager, Operations
Research Institution:
NATIONAL ANIMAL DISEASE CENTER
RI Contact:
Adrianna D. Hewings
Abstract:
The human infectivity of Chronic Wasting Disease (CWD) is unclear. Current diagnostics rely upon post-mortem examination and late-term disease. Migratory B cells are emerging as likely candidates for blood-borne infectivity, and therefore, a logical target for sensitive antemortem diagnosis. We… More

The use of proteomics for surrogate markers of prion infection

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$99,991.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Christopher Mateo, Operations Manager
Abstract:
Prion diseases are unique, in that their exceptionally long incubation period makes it difficult to diagnose prior to end-stage disease. While many diagnostic assays for infectious diseases rely upon detection of specific immunity, prion diseases apparently provoke no detectable immune response. … More

The use of proteomics for surrogate markers of prion infection

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$749,985.00
Agency / Branch:
DOD / OSD
Principal Investigator:
Christopher Mateo, Operations Manager
Abstract:
Transmissible Spongiform Encephalopathies are a new class of infectious diseases, as the causative agent appears to be an altered form of a normal cellular protein capable of self-replication. While these diseases originally gained attention as food-borne illnesses, it has become apparent that… More

Sensitive ImmunoPCR of Blood-Borne Prions

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$83,878.00
Agency:
HHS
Principal Investigator:
Elliot Stevens
Abstract:
DESCRIPTION (provided by applicant): Transmissible Spongiform Encephalopathies are a family of progressive, invariably fatal neurological disorders. Unlike more conventional infectious diseases, TSEs appear to be caused by a new family of infectious agents , a misfolded self protein (PrPd) capable… More